[HTML] frontiersin.org

[HTML][HTML] ZDQ-0620, a novel phosphatidylinositol 3-kinase inhibitor, inhibits colorectal carcinoma cell proliferation and suppresses angiogenesis by attenuating PI3K …

X Qin, M Liu, C Xu, B Xing, X Xu, Y Wu, H Ding… - Frontiers in …, 2022 - frontiersin.org
The PI3K/AKT pathway plays a central role in human cancers, aberrant activation of this
pathway is associated with tumorigenesis, cancer progression and angiogenesis. Based on …
被引用次数：4 相关文章

[引用][C] ZDQ-0620, a Novel Phosphatidylinositol 3-Kinase Inhibitor, Inhibits Colorectal Carcinoma Cell Proliferation and Suppresses Angiogenesis by Attenuating PI3K …

X Qin, M Liu, C Xu, B Xing, X Xu, Y Wu… - Frontiers in Oncology …, 2022 - jglobal.jst.go.jp
ZDQ-0620, a Novel Phosphatidylinositol 3-Kinase Inhibitor, Inhibits Colorectal Carcinoma
Cell Proliferation and Suppresses Angiogenesis by Attenuating PI3K/AKT/mTOR Pathway …

ZDQ-0620, a Novel Phosphatidylinositol 3-Kinase Inhibitor, Inhibits Colorectal Carcinoma Cell Proliferation and Suppresses Angiogenesis by Attenuating PI3K/AKT …

X Qin, M Liu, C Xu, B Xing, X Xu, Y Wu, H Ding… - Frontiers in …, 2022 - europepmc.org
Abstract The PI3K/AKT pathway plays a central role in human cancers, aberrant activation of
this pathway is associated with tumorigenesis, cancer progression and angiogenesis. Based …
[HTML] nih.gov

[HTML][HTML] ZDQ-0620, a Novel Phosphatidylinositol 3-Kinase Inhibitor, Inhibits Colorectal Carcinoma Cell Proliferation and Suppresses Angiogenesis by Attenuating …

X Qin, M Liu, C Xu, B Xing, X Xu, Y Wu, H Ding… - Frontiers in …, 2022 - ncbi.nlm.nih.gov
Abstract The PI3K/AKT pathway plays a central role in human cancers, aberrant activation of
this pathway is associated with tumorigenesis, cancer progression and angiogenesis. Based …

ZDQ-0620, a Novel Phosphatidylinositol 3-Kinase Inhibitor, Inhibits Colorectal Carcinoma Cell Proliferation and Suppresses Angiogenesis by Attenuating PI3K/AKT …

X Qin, M Liu, C Xu, B Xing, X Xu, Y Wu… - Frontiers in …, 2022 - pubmed.ncbi.nlm.nih.gov
The PI3K/AKT pathway plays a central role in human cancers, aberrant activation of this
pathway is associated with tumorigenesis, cancer progression and angiogenesis. Based on …

ZDQ-0620, a Novel Phosphatidylinositol 3-Kinase Inhibitor, Inhibits Colorectal Carcinoma Cell Proliferation and Suppresses Angiogenesis by Attenuating PI3K/AKT …

X Qin, M Liu, C Xu, B Xing, X Xu, Y Wu, H Ding… - Frontiers in …, 2022 - europepmc.org
Abstract The PI3K/AKT pathway plays a central role in human cancers, aberrant activation of
this pathway is associated with tumorigenesis, cancer progression and angiogenesis. Based …